{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:00:58Z","timestamp":1791928858287,"version":"4.3.4"},"reference-count":118,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"13","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2025,10,15]]},"DOI":"10.1167\/iovs.66.13.24","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T13:01:36Z","timestamp":1760533296000},"page":"24","source":"Crossref","is-referenced-by-count":4,"title":["Elevated Neurodegeneration Markers in the Aqueous Humor of Primary Open Angle and Normal Tension Glaucoma Patients Correlate With Disease Severity"],"prefix":"10.1167","volume":"66","author":[{"given":"Archana Padmanabhan","family":"Nair","sequence":"first","affiliation":[{"name":"GROW Research Laboratory, Narayana Netralaya Foundation, Bangalore, India"},{"name":"Manipal Academy of Higher Education, Manipal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushma","family":"Tejwani","sequence":"additional","affiliation":[{"name":"Narayana Nethralaya Eye Hospital, Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoruba","family":"Dinakaran","sequence":"additional","affiliation":[{"name":"Narayana Nethralaya Eye Hospital, Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naren","family":"Shetty","sequence":"additional","affiliation":[{"name":"Narayana Nethralaya Eye Hospital, Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Shetty","sequence":"additional","affiliation":[{"name":"Narayana Nethralaya Eye Hospital, Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arkasubhra","family":"Ghosh","sequence":"additional","affiliation":[{"name":"GROW Research Laboratory, Narayana Netralaya Foundation, Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swaminathan","family":"Sethu","sequence":"additional","affiliation":[{"name":"GROW Research Laboratory, Narayana Netralaya Foundation, Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"issue":"2","key":"bib1","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1016\/S2214-109X(20)30489-7","article-title":"Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study","volume":"9","author":"GBD 2019 Blindness and Vision Impairment Collaborators; Vision Loss Expert Group of the Global Burden of Disease Study","year":"2021","journal-title":"Lancet Glob Health"},{"issue":"5","key":"bib2","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.3390\/jcm12051828","article-title":"The global burden of glaucoma: findings from the Global Burden of Disease 2019 study and predictions by Bayesian Age-Period-Cohort Analysis","volume":"12","author":"Lin","year":"2023","journal-title":"J Clin Med"},{"issue":"11","key":"bib3","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"issue":"18","key":"bib4","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA"},{"issue":"5","key":"bib5","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/s41433-018-0042-2","article-title":"Normal tension glaucoma: review of current understanding and mechanisms of the pathogenesis","volume":"32","author":"Killer","year":"2018","journal-title":"Eye (Lond)"},{"issue":"4","key":"bib6","doi-asserted-by":"publisher","first-page":"495","DOI":"10.4103\/ijo.IJO_1130_17","article-title":"Simplifying \u201ctarget\u201d intraocular pressure for different stages of primary open-angle glaucoma and primary angle-closure glaucoma","volume":"66","author":"Sihota","year":"2018","journal-title":"Indian J Ophthalmol"},{"issue":"3","key":"bib7","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.mcna.2021.01.004","article-title":"Glaucoma","volume":"105","author":"Kang","year":"2021","journal-title":"Med Clin North Am"},{"issue":"9","key":"bib8","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1111\/j.1442-9071.2006.01368.x","article-title":"Failure of medical therapy despite normal intraocular pressure","volume":"34","author":"Walland","year":"2006","journal-title":"Clin Exp Ophthalmol"},{"issue":"2","key":"bib9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/ICU.0000000000000640","article-title":"Management of the glaucoma patient progressing at low normal intraocular pressure","volume":"31","author":"Wang","year":"2020","journal-title":"Curr Opin Ophthalmol"},{"issue":"6","key":"bib10","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1001\/archopht.120.6.701","article-title":"The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma","volume":"120","author":"Kass","year":"2002","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"bib11","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0002-9394(98)00223-2","article-title":"Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group","volume":"126","year":"1998","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"bib12","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","article-title":"Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial","volume":"120","author":"Heijl","year":"2002","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"bib13","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1136\/bjo-2023-323708","article-title":"Survival of medical treatment success in primary open-angle glaucoma and ocular hypertension","volume":"108","author":"Fu","year":"2024","journal-title":"Br J Ophthalmol"},{"issue":"4\u20135","key":"bib14","first-page":"588","article-title":"Some clinical implications of the collaborative normal tension glaucoma study","volume":"106","author":"Drance","year":"2004","journal-title":"Klin Oczna"},{"issue":"12","key":"bib15","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1016\/j.ophtha.2019.07.023","article-title":"Corneal biomechanics and visual field progression in eyes with seemingly well-controlled intraocular pressure","volume":"126","author":"Susanna","year":"2019","journal-title":"Ophthalmology"},{"issue":"1","key":"bib16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.molmed.2017.11.004","article-title":"Monitoring neurodegeneration in glaucoma: therapeutic implications","volume":"24","author":"Ban","year":"2018","journal-title":"Trends Mol Med"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.expneurol.2012.01.014","article-title":"Intrinsic axonal degeneration pathways are critical for glaucomatous damage","volume":"246","author":"Howell","year":"2013","journal-title":"Exp Neurol"},{"key":"bib18","first-page":"60","article-title":"Molecular mechanisms of retinal ganglion cell degeneration in glaucoma and future prospects for cell body and axonal protection","volume":"6","author":"Munemasa","year":"2012","journal-title":"Front Cell Neurosci"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"1354569","DOI":"10.3389\/fncel.2024.1354569","article-title":"Glaucoma: from pathogenic mechanisms to retinal glial cell response to damage","volume":"18","author":"Fernandez-Albarral","year":"2024","journal-title":"Front Cell Neurosci"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"995369","DOI":"10.3389\/fnana.2022.995369","article-title":"The heterogeneity of astrocytes in glaucoma","volume":"16","author":"Tang","year":"2022","journal-title":"Front Neuroanat"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"101169","DOI":"10.1016\/j.preteyeres.2023.101169","article-title":"Activation of retinal glial cells contributes to the degeneration of ganglion cells in experimental glaucoma","volume":"93","author":"Miao","year":"2023","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"bib22","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.3390\/ijms24032747","article-title":"Astrocyte immune functions and glaucoma","volume":"24","author":"Shinozaki","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"21","key":"bib23","doi-asserted-by":"publisher","first-page":"5785","DOI":"10.1523\/JNEUROSCI.3986-15.2016","article-title":"Tau accumulation, altered phosphorylation, and missorting promote neurodegeneration in glaucoma","volume":"36","author":"Chiasseu","year":"2016","journal-title":"J Neurosci"},{"issue":"21","key":"bib24","doi-asserted-by":"publisher","first-page":"6900","DOI":"10.3390\/jcm12216900","article-title":"Glaucoma as a tauopathy - is it the missing piece in the glaucoma puzzle?","volume":"12","author":"Passaro","year":"2023","journal-title":"J Clin Med"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"101226","DOI":"10.1016\/j.mam.2023.101226","article-title":"Ubiquitin proteasome system and glaucoma: a survey of genetics and molecular biology studies supporting a link with pathogenic and therapeutic relevance","volume":"94","author":"Pandino","year":"2023","journal-title":"Mol Aspects Med"},{"issue":"S267","key":"bib26","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1755-3768.2022.112","article-title":"The ubiquitin-proteasomal pathway in glaucomatous lamina cribrosa cells","volume":"100","author":"McElhinney","year":"2022","journal-title":"Acta Ophthalmologica"},{"issue":"7","key":"bib27","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1093\/brain\/awaa098","article-title":"Neurofilaments: neurobiological foundations for biomarker applications","volume":"143","author":"Gafson","year":"2020","journal-title":"Brain"},{"issue":"7","key":"bib28","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.3390\/biomedicines10071760","article-title":"Biomarkers of neurodegenerative diseases: biology, taxonomy, clinical relevance, and current research status","volume":"10","author":"Konickova","year":"2022","journal-title":"Biomedicines"},{"issue":"100062","key":"bib29","doi-asserted-by":"crossref","first-page":"100062","DOI":"10.1016\/j.bionps.2023.100062","article-title":"Fluid biomarkers for the diagnosis of neurodegenerative diseases","volume":"8","author":"Luebke","year":"2023","journal-title":"Biomark Neuropsychiatry"},{"issue":"1","key":"bib30","doi-asserted-by":"publisher","first-page":"e16226","DOI":"10.1111\/jnc.16226","article-title":"The GFAP proteoform puzzle: how to advance GFAP as a fluid biomarker in neurological diseases","volume":"169","author":"Gogishvili","year":"2025","journal-title":"J Neurochem"},{"issue":"9","key":"bib31","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S1474-4422(18)30231-X","article-title":"Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study","volume":"17","author":"Bazarian","year":"2018","journal-title":"Lancet Neurol"},{"issue":"12","key":"bib32","doi-asserted-by":"publisher","first-page":"e168553","DOI":"10.1172\/JCI168553","article-title":"Tau pathology in neurodegenerative disease: disease mechanisms and therapeutic avenues","volume":"133","author":"Samudra","year":"2023","journal-title":"J Clin Invest"},{"issue":"1","key":"bib33","doi-asserted-by":"publisher","first-page":"e14397","DOI":"10.1002\/alz.14397","article-title":"Plasma p-tau immunoassays in clinical research for Alzheimer's disease","volume":"21","author":"Teunissen","year":"2025","journal-title":"Alzheimers Dement"},{"issue":"2","key":"bib34","doi-asserted-by":"publisher","first-page":"658","DOI":"10.14336\/AD.2024.0286","article-title":"Amyloid-beta and phosphorylated tau are the key biomarkers and predictors of Alzheimer's disease","volume":"16","author":"Pradeepkiran","year":"2024","journal-title":"Aging Dis"},{"issue":"4","key":"bib35","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1002\/alz.12790","article-title":"Relationship of serum beta-synuclein with blood biomarkers and brain atrophy","volume":"19","author":"Oeckl","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"4","key":"bib36","doi-asserted-by":"publisher","first-page":"e70146","DOI":"10.1002\/alz.70146","article-title":"Early increase of the synaptic blood marker beta-synuclein in asymptomatic autosomal dominant Alzheimer's disease","volume":"21","author":"Oeckl","year":"2025","journal-title":"Alzheimers Dement"},{"issue":"6","key":"bib37","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","article-title":"Biomarkers for neurodegenerative diseases","volume":"27","author":"Hansson","year":"2021","journal-title":"Nat Med"},{"issue":"6","key":"bib38","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1136\/jnnp-2022-330958","article-title":"Blood biomarkers: ready for clinical practice?","volume":"94","author":"Coulthard","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41573-025-01165-w","article-title":"Biomarker-guided decision making in clinical drug development for neurodegenerative disorders","volume":"24","author":"Cummings","year":"2025","journal-title":"Nat Rev Drug Discov"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"106730","DOI":"10.1016\/j.nbd.2024.106730","article-title":"Linking human cerebral and ocular waste clearance: insights from tear fluid and ultra-high field MRI","volume":"203","author":"van der Thiel","year":"2024","journal-title":"Neurobiol Dis"},{"issue":"1","key":"bib41","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/s12883-023-03335-y","article-title":"Tear biomarkers for Alzheimer's disease screening and diagnosis (the TearAD study): design and rationale of an observational longitudinal multicenter study","volume":"23","author":"van de Sande","year":"2023","journal-title":"BMC Neurol"},{"issue":"1","key":"bib42","doi-asserted-by":"publisher","first-page":"22675","DOI":"10.1038\/s41598-021-01993-x","article-title":"Association of tear fluid amyloid and tau levels with disease severity and neurodegeneration","volume":"11","author":"Gijs","year":"2021","journal-title":"Sci Rep"},{"issue":"3","key":"bib43","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1007\/s11357-022-00576-6","article-title":"Elevated alpha-synuclein and NfL levels in tear fluids and decreased retinal microvascular densities in patients with Parkinson's disease","volume":"44","author":"Lin","year":"2022","journal-title":"Geroscience"},{"issue":"13","key":"bib44","first-page":"2585","article-title":"Beta-amyloid protein protein precursor expression in lacrimal glands and tear fluid","volume":"37","author":"Van Setten","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"bib45","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s13195-024-01556-y","article-title":"Neurodegenerative biomarkers in different chambers of the eye relative to plasma: an agreement validation study","volume":"16","author":"Sampani","year":"2024","journal-title":"Alzheimers Res Ther"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"110538","DOI":"10.1016\/j.exer.2025.110538","article-title":"Distinct relationships between secreted factors measured in matched tear fluid, aqueous, vitreous, and plasma samples from patients with retinal conditions","volume":"259","author":"Vaidya","year":"2025","journal-title":"Exp Eye Res"},{"issue":"9","key":"bib47","doi-asserted-by":"publisher","first-page":"e91455","DOI":"10.1172\/jci.insight.91455","article-title":"GDF15 is elevated in mice following retinal ganglion cell death and in glaucoma patients","volume":"2","author":"Ban","year":"2017","journal-title":"JCI Insight"},{"issue":"10","key":"bib48","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1136\/bjo-2021-320828","article-title":"Neurofilament light chain: a new marker for neuronal decay in the anterior chamber fluid of patients with glaucoma","volume":"107","author":"Woltsche","year":"2023","journal-title":"Br J Ophthalmol"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.2147\/OPTH.S438358","article-title":"Neurofilament light chain in aqueous humor as a marker of neurodegeneration in glaucoma","volume":"17","author":"Lin","year":"2023","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"bib50","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1167\/tvst.14.2.24","article-title":"Evaluation of serum and aqueous humor neurofilament light chain as markers of neurodegeneration in glaucoma","volume":"14","author":"Lin","year":"2025","journal-title":"Transl Vis Sci Technol"},{"issue":"2","key":"bib51","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1136\/bjo.86.2.238","article-title":"The definition and classification of glaucoma in prevalence surveys","volume":"86","author":"Foster","year":"2002","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"bib52","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/APO.0000000000000177","article-title":"Update on the prevalence, etiology, diagnosis, and monitoring of normal-tension glaucoma","volume":"5","author":"Kim","year":"2016","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"bib53","doi-asserted-by":"publisher","first-page":"100976","DOI":"10.1016\/j.preteyeres.2021.100976","article-title":"Detecting retinal cell stress and apoptosis with DARC: progression from lab to clinic","volume":"86","author":"Cordeiro","year":"2022","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"bib54","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1167\/tvst.13.1.20","article-title":"Real-time imaging of single retinal cell apoptosis in a non-human primate ocular hypertension model","volume":"13","author":"Ishikawa","year":"2024","journal-title":"Transl Vis Sci Technol"},{"issue":"15","key":"bib55","doi-asserted-by":"publisher","first-page":"6073","DOI":"10.7150\/ijbs.102551","article-title":"Annexin-V binds subpopulation of immune cells altering its interpretation as an in vivo biomarker for apoptosis in the retina","volume":"20","author":"Miyagishima","year":"2024","journal-title":"Int J Biol Sci"},{"issue":"2","key":"bib56","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1080\/02713683.2017.1396617","article-title":"Brain-derived neurotrophic factor in patients with primary open-angle glaucoma and age-related cataract","volume":"43","author":"Shpak","year":"2018","journal-title":"Curr Eye Res"},{"key":"bib57","first-page":"39","article-title":"Glial cell line-derived neurotrophic factor (GDNF) in patients with primary open-angle glaucoma and age-related cataract","volume":"28","author":"Shpak","year":"2022","journal-title":"Mol Vis"},{"key":"bib58","first-page":"799","article-title":"Ciliary neurotrophic factor in patients with primary open-angle glaucoma and age-related cataract","volume":"23","author":"Shpak","year":"2017","journal-title":"Mol Vis"},{"issue":"5\u20136","key":"bib59","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1089\/neu.2022.0249","article-title":"Serum tau, neurofilament light chain, glial fibrillary acidic protein, and ubiquitin carboxyl-terminal hydrolase L1 are associated with the chronic deterioration of neurobehavioral symptoms after traumatic brain injury","volume":"40","author":"Lange","year":"2023","journal-title":"J Neurotrauma"},{"issue":"21","key":"bib60","doi-asserted-by":"publisher","first-page":"e2120","DOI":"10.1212\/WNL.0000000000200258","article-title":"Blood neurofilament light in progressive multiple sclerosis: post hoc analysis of 2 randomized controlled trials","volume":"98","author":"Leppert","year":"2022","journal-title":"Neurology"},{"issue":"2","key":"bib61","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJMoa2003715","article-title":"Phase 1-2 trial of antisense oligonucleotide tofersen for SOD1 ALS","volume":"383","author":"Miller","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"bib62","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/ene.14063","article-title":"Serum neurofilament light chain at time of diagnosis is an independent prognostic factor of survival in amyotrophic lateral sclerosis","volume":"27","author":"Thouvenot","year":"2020","journal-title":"Eur J Neurol"},{"issue":"1","key":"bib63","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1212\/WNL.0000000000009559","article-title":"Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS","volume":"95","author":"Benatar","year":"2020","journal-title":"Neurology"},{"key":"bib64","first-page":"83","article-title":"Comparative study of the three neurofilament subunits within pig and human retinal ganglion cells","volume":"10","author":"Ruiz-Ederra","year":"2004","journal-title":"Mol Vis"},{"key":"bib65","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.exer.2014.10.006","article-title":"Sectoral variations in the distribution of axonal cytoskeleton proteins in the human optic nerve head","volume":"128","author":"Kang","year":"2014","journal-title":"Exp Eye Res"},{"key":"bib66","doi-asserted-by":"publisher","first-page":"1091697","DOI":"10.3389\/fneur.2023.1091697","article-title":"Alteration of neurofilament heavy chain and its phosphoforms reveals early subcellular damage beyond the optic nerve head in glaucoma","volume":"14","author":"Zhou","year":"2023","journal-title":"Front Neurol"},{"issue":"8","key":"bib67","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.1167\/iovs.06-1002","article-title":"Axonal transport and cytoskeletal changes in the laminar regions after elevated intraocular pressure","volume":"48","author":"Balaratnasingam","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"bib68","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1523\/JNEUROSCI.4443-07.2008","article-title":"Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma","volume":"28","author":"Buckingham","year":"2008","journal-title":"J Neurosci"},{"issue":"3","key":"bib69","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.exer.2006.03.007","article-title":"Intravitreal injection of endothelin-1 caused optic nerve damage following to ocular hypoperfusion in rabbits","volume":"83","author":"Sasaoka","year":"2006","journal-title":"Exp Eye Res"},{"key":"bib70","doi-asserted-by":"publisher","first-page":"1027705","DOI":"10.3389\/fnagi.2022.1027705","article-title":"Association of cognitive function with neurofilament light chain in the aqueous humor of human eye","volume":"14","author":"Bai","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"bib71","doi-asserted-by":"publisher","first-page":"1310226","DOI":"10.3389\/fopht.2023.1310226","article-title":"Glial cells as a promising therapeutic target of glaucoma: beyond the IOP","volume":"3","author":"Shinozaki","year":"2023","journal-title":"Front Ophthalmol (Lausanne)"},{"issue":"3","key":"bib72","doi-asserted-by":"publisher","first-page":"e18305","DOI":"10.1371\/journal.pone.0018305","article-title":"Inhibition of reactive gliosis attenuates excitotoxicity-mediated death of retinal ganglion cells","volume":"6","author":"Ganesh","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"bib73","doi-asserted-by":"publisher","first-page":"188","DOI":"10.4172\/2155-9899.1000188","article-title":"Astrocyte reactivity: a biomarker for retinal ganglion cell health in retinal neurodegeneration","volume":"5","author":"Formichella","year":"2014","journal-title":"J Clin Cell Immunol"},{"issue":"1","key":"bib74","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41583-022-00641-1","article-title":"Astrocyte contribution to dysfunction, risk and progression in neurodegenerative disorders","volume":"24","author":"Brandebura","year":"2023","journal-title":"Nat Rev Neurosci"},{"issue":"8","key":"bib75","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1089\/neu.2020.7039","article-title":"Traumatic optic nerve injury elevates plasma biomarkers of traumatic brain injury in a porcine model","volume":"38","author":"Bramblett","year":"2021","journal-title":"J Neurotrauma"},{"issue":"4","key":"bib76","first-page":"1088","article-title":"Immunohistologic evidence for retinal glial cell changes in human glaucoma","volume":"43","author":"Wang","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"bib77","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1167\/iovs.02-1136","article-title":"Immunohistochemical assessment of the glial mitogen-activated protein kinase activation in glaucoma","volume":"44","author":"Tezel","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"bib78","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.14336\/AD.2024.0103","article-title":"Glial cell activation and immune responses in glaucoma: a systematic review of human postmortem studies of the retina and optic nerve","volume":"15","author":"Salkar","year":"2024","journal-title":"Aging Dis"},{"issue":"5","key":"bib79","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3390\/ph18050694","article-title":"Citicoline and coenzyme Q10: therapeutic agents for glial activation reduction in ocular hypertension","volume":"18","author":"Matamoros","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"issue":"2","key":"bib80","doi-asserted-by":"publisher","first-page":"e0313556","DOI":"10.1371\/journal.pone.0313556","article-title":"Transient ocular hypertension remodels astrocytes through S100B","volume":"20","author":"Huang","year":"2025","journal-title":"PLoS One"},{"issue":"2","key":"bib81","doi-asserted-by":"publisher","first-page":"265","DOI":"10.2460\/ajvr.69.2.265","article-title":"Comparison of the distribution of glial fibrillary acidic protein, heat shock protein 60, and hypoxia-inducible factor-1alpha in retinas from glaucomatous and normal canine eyes","volume":"69","author":"Savagian","year":"2008","journal-title":"Am J Vet Res"},{"issue":"2","key":"bib82","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/glia.20000","article-title":"Muller cell response to laser-induced increase in intraocular pressure in rats","volume":"47","author":"Woldemussie","year":"2004","journal-title":"Glia"},{"issue":"1","key":"bib83","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000027470","article-title":"Vascular and glial changes in the retrolaminar optic nerve in glaucomatous monkey eyes","volume":"214","author":"Furuyoshi","year":"2000","journal-title":"Ophthalmologica"},{"issue":"1","key":"bib84","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s40478-022-01427-3","article-title":"Widespread retina and optic nerve neuroinflammation in enucleated eyes from glaucoma patients","volume":"10","author":"Rutigliani","year":"2022","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"bib85","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.jphs.2014.12.019","article-title":"GFAP antibodies show protective effect on oxidatively stressed neuroretinal cells via interaction with ERP57","volume":"127","author":"Wilding","year":"2015","journal-title":"J Pharmacol Sci"},{"issue":"3","key":"bib86","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1167\/iovs.63.3.8","article-title":"Aqueous humor biomarkers of retinal glial cell activation in patients with or without age-related cataracts and with different stages of diabetic retinopathy","volume":"63","author":"Zhao","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"bib87","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1167\/iovs.15-16554","article-title":"Aqueous humor biomarkers of Muller cell activation in diabetic eyes","volume":"56","author":"Vujosevic","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"bib88","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1167\/iovs.61.5.22","article-title":"Increased glial fibrillary acid protein and vimentin in vitreous fluid as a biomarker for proliferative vitreoretinopathy","volume":"61","author":"Lee","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"bib89","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1007\/s00417-015-3127-7","article-title":"Elevated vitreous body glial fibrillary acidic protein in retinal diseases","volume":"253","author":"Junemann","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"bib90","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00417-019-04289-z","article-title":"Muller cells and choriocapillaris in the pathogenesis of geographic atrophy secondary to age-related macular degeneration","volume":"257","author":"Pilotto","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"bib91","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.3390\/ijms22052360","article-title":"Role of retinal amyloid-beta in neurodegenerative diseases: overlapping mechanisms and emerging clinical applications","volume":"22","author":"Wang","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4","key":"bib92","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.preteyeres.2011.02.004","article-title":"Parallel findings in age-related macular degeneration and Alzheimer's disease","volume":"30","author":"Ohno-Matsui","year":"2011","journal-title":"Prog Retin Eye Res"},{"issue":"6","key":"bib93","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1111\/j.1471-4159.2010.06724.x","article-title":"Induction of amyloid precursor protein by the neurotoxic peptide, amyloid-beta 25-35, causes retinal ganglion cell death","volume":"113","author":"Tsuruma","year":"2010","journal-title":"J Neurochem"},{"issue":"33","key":"bib94","doi-asserted-by":"publisher","first-page":"13444","DOI":"10.1073\/pnas.0703707104","article-title":"Targeting amyloid-beta in glaucoma treatment","volume":"104","author":"Guo","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"bib95","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrn2194","article-title":"Tau-mediated neurodegeneration in Alzheimer's disease and related disorders","volume":"8","author":"Ballatore","year":"2007","journal-title":"Nat Rev Neurosci"},{"issue":"8","key":"bib96","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/eye.2015.100","article-title":"Dementia of the eye: the role of amyloid beta in retinal degeneration","volume":"29","author":"Ratnayaka","year":"2015","journal-title":"Eye (Lond)"},{"issue":"1","key":"bib97","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.bbrc.2012.05.085","article-title":"Elevated amyloid beta production in senescent retinal pigment epithelium, a possible mechanism of subretinal deposition of amyloid beta in age-related macular degeneration","volume":"423","author":"Wang","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"bib98","doi-asserted-by":"publisher","first-page":"e13127","DOI":"10.1371\/journal.pone.0013127","article-title":"Viewing ageing eyes: diverse sites of amyloid Beta accumulation in the ageing mouse retina and the up-regulation of macrophages","volume":"5","author":"Hoh Kam","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"bib99","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1097\/IJG.0000000000002496","article-title":"Identification of retinal amyloid-beta in ex vivo human glaucoma eyes using a novel ocular tracer","volume":"34","author":"Pilotte","year":"2025","journal-title":"J Glaucoma"},{"issue":"3","key":"bib100","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1023\/A:1022949121078","article-title":"Alzheimer's peptide and serine proteinase inhibitors in glaucoma and exfoliation syndrome","volume":"106","author":"Janciauskiene","year":"2003","journal-title":"Doc Ophthalmol"},{"issue":"5","key":"bib101","first-page":"662","article-title":"Amyloid beta peptides and cognitive functions in patients with pseudoexfoliation syndrome","volume":"41","author":"Lesiewska","year":"2016","journal-title":"Curr Eye Res"},{"issue":"5","key":"bib102","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1167\/tvst.9.5.21","article-title":"Evaluating the correlation between Alzheimer's amyloid-beta peptides and glaucoma in human aqueous humor","volume":"9","author":"Cappelli","year":"2020","journal-title":"Transl Vis Sci Technol"},{"issue":"1\u20132","key":"bib103","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/08820538.2021.1883679","article-title":"Highly expressed amyloid beta-42 of aqueous humor in patients with neovascular macular degeneration","volume":"36","author":"Zhu","year":"2021","journal-title":"Semin Ophthalmol"},{"issue":"3","key":"bib104","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.3233\/JAD-230167","article-title":"Vitreous humor biomarkers reflect pathological changes in the brain for Alzheimer's disease and chronic traumatic encephalopathy","volume":"93","author":"Vig","year":"2023","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"bib105","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s10384-004-0156-x","article-title":"Vitreous fluid levels of beta-amyloid((1-42)) and tau in patients with retinal diseases","volume":"49","author":"Yoneda","year":"2005","journal-title":"Jpn J Ophthalmol"},{"issue":"1","key":"bib106","doi-asserted-by":"publisher","first-page":"9304","DOI":"10.1038\/s41598-017-09009-3","article-title":"Analytical performance of reagent for assaying tau protein in human plasma and feasibility study screening neurodegenerative diseases","volume":"7","author":"Yang","year":"2017","journal-title":"Sci Rep"},{"issue":"11","key":"bib107","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1093\/brain\/awaa286","article-title":"Longitudinal plasma p-tau217 is increased in early stages of Alzheimer's disease","volume":"143","author":"Mattsson-Carlgren","year":"2020","journal-title":"Brain"},{"issue":"1","key":"bib108","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3129\/i07-185","article-title":"Retinal tau pathology in human glaucomas","volume":"43","author":"Gupta","year":"2008","journal-title":"Can J Ophthalmol"},{"issue":"10","key":"bib109","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1002\/acn3.51873","article-title":"High diagnostic performance of plasma and cerebrospinal fluid beta-synuclein for sporadic Creutzfeldt-Jakob disease","volume":"10","author":"Abu-Rumeileh","year":"2023","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"bib110","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/biom12010142","article-title":"\u00df-synuclein: an enigmatic protein with diverse functionality","volume":"12","author":"Hayashi","year":"2022","journal-title":"Biomolecules"},{"issue":"1","key":"bib111","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/ana.23905","article-title":"Beta-synuclein aggregates and induces neurodegeneration in dopaminergic neurons","volume":"74","author":"Taschenberger","year":"2013","journal-title":"Ann Neurol"},{"key":"bib112","doi-asserted-by":"crossref","first-page":"8642135","DOI":"10.1155\/2020\/8642135","article-title":"Hydrogen sulfide and beta-synuclein are involved and interlinked in the aging glaucomatous retina","volume":"2020","author":"Liu","year":"2020","journal-title":"J Ophthalmol"},{"key":"bib113","doi-asserted-by":"publisher","first-page":"101856","DOI":"10.1016\/j.arr.2023.101856","article-title":"Role of UCHL1 in the pathogenesis of neurodegenerative diseases and brain injury","volume":"86","author":"Mi","year":"2023","journal-title":"Ageing Res Rev"},{"key":"bib114","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.brainres.2010.07.019","article-title":"Expression in the mammalian retina of parkin and UCH-L1, two components of the ubiquitin-proteasome system","volume":"1352","author":"Esteve-Rudd","year":"2010","journal-title":"Brain Res"},{"key":"bib115","first-page":"1770","article-title":"Changes in ocular aquaporin-4 (AQP4) expression following retinal injury","volume":"14","author":"Dibas","year":"2008","journal-title":"Mol Vis"},{"issue":"3","key":"bib116","doi-asserted-by":"publisher","first-page":"115382","DOI":"10.1016\/j.celrep.2025.115382","article-title":"Secreted neurofilament light chain after neuronal damage induces myeloid cell activation and neuroinflammation","volume":"44","author":"Kahn","year":"2025","journal-title":"Cell Rep"},{"issue":"1","key":"bib117","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13195-020-00677-4","article-title":"Neurofilament light chain in the vitreous humor of the eye","volume":"12","author":"Subramanian","year":"2020","journal-title":"Alzheimers Res Ther"},{"issue":"10","key":"bib118","doi-asserted-by":"publisher","first-page":"175","DOI":"10.21037\/atm.2018.04.23","article-title":"Tau in neurodegenerative disease","volume":"6","author":"Gao","year":"2018","journal-title":"Ann Transl Med"}],"container-title":["Investigative Ophthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2810962","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:32:00Z","timestamp":1791927120000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2810962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":118,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2025,10,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.66.13.24","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,15]]}}}